Secura Bio, Inc.

Secura Bio, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Secura Bio was established in 2019 with a singular mission: to close the gap between innovative oncology therapies and the patients who need them most. Our high-touch approach is informed by our decades of experience shaping the impact of oncology’s largest clinical and market opportunities. We leverage our experience to embrace the challenges of commercializing and developing therapies for the most difficult-to-treat patient populations.

Company Details

Employees
51
Founded
-
Address
Las Vegas, Nevada 89134, Us
Phone
(858) 251-1414
Email
MA****@****BIO.COM
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Las Vegas, Nevada
Looking for a particular Secura Bio, Inc. employee's phone or email?

Secura Bio, Inc. Questions

News

Secura Bio Announces First Patient Dosed in Phase 3 TERZO - GlobeNewswire

Secura Bio Announces First Patient Dosed in Phase 3 TERZO GlobeNewswire

Secura Bio Presented New Data from its Phase 2 PRIMO Trial of Copiktra® (Duvelisib) in Relapsed or Refractory Peripheral T-cell Lymphoma and Announced Plans for its Phase 3 TERZO Trial at the 2024 American Society of Hematology Meeting - Yahoo Finance

Secura Bio Presented New Data from its Phase 2 PRIMO Trial of Copiktra® (Duvelisib) in Relapsed or Refractory Peripheral T-cell Lymphoma and Announced Plans for its Phase 3 TERZO Trial at the 2024 American Society of Hematology Meeting Yahoo Finance

Secura Bio Appoints Charles R. Romp as Its Chief Executive Officer - PR Newswire

Secura Bio Appoints Charles R. Romp as Its Chief Executive Officer PR Newswire

New Combination Data of Secura Bio’s COPIKTRA® (duvelisib) - GlobeNewswire

New Combination Data of Secura Bio’s COPIKTRA® (duvelisib) GlobeNewswire

Secura Bio Announces the Addition of Two New Board of Directors Members - PR Newswire

Secura Bio Announces the Addition of Two New Board of Directors Members PR Newswire

Verastem to divest Copiktra rights to Secura Bio for up to $381m - Pharmaceutical Technology

Verastem to divest Copiktra rights to Secura Bio for up to $381m Pharmaceutical Technology

Secura Bio Withdraws Duvelisib Relapsed/Refractory Follicular Lymphoma Indication in the United States - OncLive

Secura Bio Withdraws Duvelisib Relapsed/Refractory Follicular Lymphoma Indication in the United States OncLive

Secura Bio Appoints Dr. Patrick Vink as Chairman of the Board of Directors - GlobeNewswire

Secura Bio Appoints Dr. Patrick Vink as Chairman of the Board of Directors GlobeNewswire

Secura Bio - The Pharma Letter

Secura Bio The Pharma Letter

Secura Bio Announces Copiktra® (duvelisib) Strategic Focus On T-cell Lymphoma And Voluntary U.S. Withdrawal Of The Relapsed Or Refractory Follicular Lymphoma Indication - PR Newswire

Secura Bio Announces Copiktra® (duvelisib) Strategic Focus On T-cell Lymphoma And Voluntary U.S. Withdrawal Of The Relapsed Or Refractory Follicular Lymphoma Indication PR Newswire

Secura Bio Withdraws Panobinostat Plus Bortezomib/Dexamethasone Myeloma Indication in the United States - OncLive

Secura Bio Withdraws Panobinostat Plus Bortezomib/Dexamethasone Myeloma Indication in the United States OncLive

Secura Bio Announces European Distribution Agreement for COPIKTRA® with Clinigen Healthcare Limited - PR Newswire

Secura Bio Announces European Distribution Agreement for COPIKTRA® with Clinigen Healthcare Limited PR Newswire

Secura Bio Signs Agreement to Acquire Global Rights to Oncology Drug Copiktra® - PR Newswire

Secura Bio Signs Agreement to Acquire Global Rights to Oncology Drug Copiktra® PR Newswire

Secura Bio Acquires Global Rights To Farydak® - PR Newswire

Secura Bio Acquires Global Rights To Farydak® PR Newswire

Secura Bio Announces U.S. Withdrawal of FARYDAK ® (panobinostat) NDA - PR Newswire

Secura Bio Announces U.S. Withdrawal of FARYDAK ® (panobinostat) NDA PR Newswire

Top Secura Bio, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant